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Variable No TA TA P
Limbs at risk, No. 128 64 —
Gender (%) 51 71 .16
Age, mean  SD, yrs 69  16 69  14 .1
Rest pain/tissue loss, % 71 94 .0001a
TASC C and D lesions, % 50 61 .17
Mortality, % 0.8 0.0 .1
Morbidity, % 9.4 9.4 .1
Outcomes at 5 years, %
Freedom from recurrent
symptoms
78 70 .04a
Limb salvage 78 69 .04a
Primary patency 59 55 .84
Assisted primary patency 69 79 .33
Secondary patency 71 79 .33
aStatistically significant
Treatment of Type II Endoleaks: Coil Embolization of Lumbar Vessels
Has Poor Long-Term Success
Katherine A. Gallagher, MD, Andrew J. Meltzer, MD, Asad Khan, MD,
Peter Connolly, MD, Fran Aiello, MD, Gautam Shrikhande, MD, Rajeev
Dayal, MD, John Karwowski, MD, Weill Cornell/Columbia University,
New York, NY.
Introduction: The significance of type II endoleak after EVAR is still
controversial. The lack of data for outcomes of intervention in attempts to
seal the leak only obfuscates the issue. The effectiveness and durability of
interventions are important in understanding the meaning of type II en-
doleaks. The purpose of this study was to examine outcomes after interven-
tions for type II endoleaks in our institution.
Methods: We evaluated patients who underwent type II endoleak
treatment at our tertiary care facility from 2001 to 2009. Through aggressive
surveillance imaging, 29 patients showed aneurysm enlargement and type II
endoleak. All patients underwent at least one attempt at percutaneous
intervention. Patients were followed-up postoperatively, both clinically and
radiographically, with a CT angiogram every 3 to 12 months. The outcomes
of patients with expanding type II endoleaks after intervention were ana-
lyzed. Themean postprocedural follow-up was 3.5 years (range, 1-10 years).
Results: A total of 48 interventions on 29 patients (22 men, 7 women;
mean age, 76; range 54-87 years) were performed. Of these, 15 patients
(56%) underwent multiple procedures (2): 9 (31%) underwent two, 5
(17%) had three, and 1 (3.4%) had four separate attempts at treatment.
Three ultimately required elective aortic graft explants. There were no
ruptures in these patients during the time they were followed-up. Seven
patients (24%) had continued endoleak despite multiple treatment attempts.
Of the treatment modalities used, lumbar embolization was the least suc-
cessful, with an 82% failure/recurrence rate. Conversely, IMA coil emboli-
zation had the highest success rate (Table). Three patients had minor
complications (hematoma and wound infection). There were no deaths in
this cohort.
Conclusions: Although initial success is often documented immedi-
ately angiographically, as well as in the short-term, long-term outcomes for
intervention on type II endoleak remain unknown. This study demonstrates
that most patients requiremultiple reinterventions to treat type II endoleaks,
and specifically, lumbar embolization carries a low long-term success rate.
Table. Outcomes based on endoleak intervention
Initial intervention Success Failure Secondary interventi
IMA embolization 8 3 Lumbar embolizatio
IMA embolization
Lumbar embolization 3 14 Lumbar embolizatio
Laparoscopic ligation
Explant
Thrombin gel
IMA embolizationLaparoscopic ligation 0 1 Explantarotid Stenting: The Data of Transcranial Doppler, Cognitive Tests,
nd DWI-MR May Influence Results?
oberto Gattuso, MD, Luigi Irace, MD, Jihad Jabbour, MD, Marco Maria
iuseppe Felli, MD, Federico Faccenna, MD, Antonella Laurito, MD,
lessia Alunno, MD, Anna Castiglione, MD, Bruno Gossetti, MD, Poli-
linico Umberrto, Department of Vascular Surgery, Rome, Italy
Objectives: The purpose of this study was to determine the significance
f microembolic signals (MES) recorded with transcranial Doppler (TCD)
uring carotid artery stenting (CAS). This study was based on analysis of
CD data compared both with changes induced on the brain identified by
iffusion-weighted magnetic resonance imaging (DWI-MR) and with po-
ential neurologic impairment assessed by clinical examination and cognitive
ests.
Methods: From January 2007 to December 2009, 152 patients un-
erwent CAS: 112 were asymptomatic (73.8%) and 40 were symptomatic
26.2%). As assessed by duplex scanning, all carotid stenosis were hemody-
amically significant and plaques had echomorphologic features of stability.
CAS was successfully done in 150 patients (98.7%). Cerebral protection
lter devices were used in all patients. Before the procedure, 60 minutes of
CDmonitoring was performed to detect MES in order to exclude embolic
laques. TCD monitoring was carried out throughout the procedures and
or 60 minutes after. In all patients, neurologic examination associated to
ognitive tests and DWI-MR were carried out preoperatively and postoper-
tively. Statistical analysis was performed by means the binomial test (P 
50) and the Fischer exact test.
Results: There were no deaths. Five minor stokes occurred during the
rocedure, and all were related to40MES; one major stroke was observed
ostoperatively. Fewer than 40 MES were recorded in 97 cases; in this
roup, postoperative DW-MRI showed new ischemic lesions in 18 (18.5%,
 .0009). In 48 patients was recorded MES 40 either during catheter-
zation of carotid arteries and during cerebral protection filter placement (27
atients, group A) or during stent placement and ballooning (21 cases,
roup B). Postoperative DW-MRI showed new ischemic lesions in 21 of 27
atients of group A and in all patients of group B, with a statistically
ignificant correlation. Comparison ofMRI data with those of cognitive tests
howed a statistical significant correlation between DWI lesions and post-
perative cognitive impairment (P .00001). Symptomatic patients suffer-
ng from minor or major strokes had DW-MRI lesions 20 mm2.
Conclusions: Our data suggest that even in selective patients under-
oing CAS, when intraprocedural TCD records 40 MES during stent
eployment, there is a high odds ratio new ischemic lesions will develop as
etected by DW-MRI, combined with postprocedural cognitive impair-
ent.
National Survey of The Use of Anti-Platelet Medications and Prota-
ine During Carotid Endarterectomy and Carotid Artery Stenting:
hat Is the Standard?
lizabeth M. Quiroz, BA, Ross Milner, MD, Loyola University Medical
enter, Maywood, Ill.
Objectives: The use of anticoagulation during carotid endarterectomy
CEA) and carotid artery stenting (CAS) has been standard practice for
any years. However, reversal with protamine sulfate has not been a
ormally standardized process. In our study, we assessed the anticoagulation
herapies most commonly used before, during, and after these procedures.
n addition, we evaluated the percentage of vascular surgeons that perform
arotid artery interventions.
Methods: Members of the Society of Vascular Surgery were sent an
-mail survey by Survey Monkey with 16 multiple-choice questions about
EA and CAS anticoagulation management. The questions addressed the
hoices of antiplatelet therapy before the procedure, assessment of platelet
nhibition before the procedure, anticoagulation therapy during the proce-
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